The market is segmented based on Global HbA1c Testing Market, By Product Type (Instruments, Reagents, and Kits), Technology (Ion-exchange HPLC, Enzymatic Assay, Affinity Binding Chromatography, Turbidimetric Inhibition Immunoassay, and Others), End User (Hospitals and Clinics, Diagnostic Laboratories, Homecare, Research Institution, and Others) – Industry Trends and Forecast to 2030.
.
The Global Hba1c Testing Market size was valued at USD 1826.76 USD Million in 2022.
The Global Hba1c Testing Market is projected to grow at a CAGR of 11.62% during the forecast period of 2023 to 2030.
The major players operating in the market include Abbott, BioRad Laboratories , ARKRAY , Danaher, Hoffmann,La Roche , Siemens Healthcare GmbH, TransAsia Bio,Medicals, Trinity Biotech Ireland, EKF Diagnostics, Randox Laboratories Ltd, HemoCue India, Eurolyser Diagnostica GmbH, Sekisui Diagnostics, Healio, Diazyme Laboratories , Beckman Coulter .
The market report covers data from the U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, rest of Asia- Pacific, Brazil, Argentina, rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, rest of Middle East & Africa.
Corporate Email ID Only (Avoid Using Generic mail ID such as Gmail)
Consent Preferences
We use cookies to improve your experience We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site, or closing this box, you consent to our use of cookies. Cookie Notice.
The data presented is for visualization purposes only and may not reflect actual results.
